announced today that it has received orphan drug designation for NPT520-34 for the treatment of amyotrophic lateral sclerosis
Specifically, the acquisition of Nightstar Therapeutics has provided us with two potentially first-in-class mid- to late-stage gene therapy programs in specialty ophthalmology, and we initiated two new studies in our priority areas of multiple sclerosis and amyotrophic lateral sclerosis
. We continued to allocate capital, and we remain focused on investing in the areas we believe have the highest potential return for shareholders," said Biogen CEO Michel Vounatsos.
Pharmaceutical company Aquestive Therapeutics Inc (NASDAQ:AQST) said on Tuesday that it has successfully filed a New Drug Application (NDA) with the US Food and Drug Administration (FDA) for the investigational product riluzole oral film (ROF) for the treatment of amyotrophic lateral sclerosis
The allowed claims cover the isolated cells as well as their use in the manufacture of a drug for treating a CNS disease or disorder, selected from the group consisting of: Parkinson's, multiple sclerosis, epilepsy, amyotrophic lateral sclerosis
, stroke, autoimmune encephalomyelitis, diabetic neuropathy, glaucomatous neuropathy, Alzheimer's disease and Huntingdon's disease.
Background: Ongoing efforts have been made to identify new neuroimaging markers to track amyotrophic lateral sclerosis
A Keio University research team will begin clinical tests for the treatment of amyotrophic lateral sclerosis
(ALS), administering ALS patients an existing drug used for another disease, which is confirmed to be effective in experiments with induced pluripotent stem (iPS) cells.
[ClickPress, Thu Sep 27 2018] Amyotrophic Lateral Sclerosis
(ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles.
CytRx's milestone payment follows the dosing of the first patient under the Phase 3 clinical trial evaluating arimoclomol in patients with amyotrophic lateral sclerosis
GERMANTOWN, Md., May 3, 2018 -- Comparison of data from combined cohorts in Phase 1 and 2 clinical trials versus historical controls validates plans for additional trials to evaluate benefits of using neural stem cells to treat amyotrophic lateral sclerosis
, or ALS, Neuralstem said.
He was, simultaneously, a source of inspiration for both scientists and patients of amyotrophic lateral sclerosis